Wichtige Dokumente

Gesamtdokumentation anzeigen

Fortfahren mit

1A04500

USP

L(−)-Gluconsäure-δ-lacton

Name: L(−)-Gluconsäure-δ-lacton
Brand: USP

Pharmaceutical Analytical Impurity (PAI)

Synonym(e):

L-Glucono-delta-lactone, ((3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-one)

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern

Packungsgröße	SKU	Verfügbarkeit	Preis

Über diesen Artikel

Empirische Formel (Hill-System):

C₆H₁₀O₆

CAS-Nummer:

52153-09-0

Molekulargewicht:

178.14

MDL number:

MFCD00067388

NACRES:

NA.24

Preise und Verfügbarkeit sind derzeit nicht verfügbar.

Technischer Dienst

Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.

Unterstützung erhalten

Eigenschaften

grade

pharmaceutical analytical impurity (PAI)

agency

USP

API family

canagliflozin

manufacturer/tradename

USP

mp

142-144 °C (lit.)

application(s)

pharmaceutical small molecule

format

neat

storage temp.

-10 to -25°C

SMILES string

OC[C@@H]1OC(=O)[C@@H](O)[C@H](O)[C@H]1O

InChI key

PHOQVHQSTUBQQK-KLVWXMOXSA-N

Beschreibung

General description

L-Glucono-δ-lactone is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Canagliflozin

Therapeutic Area: Endocrine

Application

L-Glucono-δ-lactone (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

USP issued SDS can be found here

Lagerklasse

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c